Arthrosi Therapeutics

$7.2M revenue • 40 employees

Last Updated Apr 29, 2025

Company Overview

Company Name

Arthrosi Therapeutics

Approx. Annual Revenue

$7.2M

Employees

40

Established

2016

About Arthrosi Therapeutics

Arthrosi Therapeutics is a clinical-stage biotech company focused on developing a therapy for gout and chronic kidney disease. Its lead drug candidate, AR882, has demonstrated promising results in lowering uric acid levels and treating gout, including tophaceous gout, in clinical trials. The company aims to provide a new era of gout treatment that can effectively reduce flares and tophi, addressing the unmet needs of the large population of gout patients.

Business Profile

Read from the Arthrosi Therapeutics website on Oct 14, 2026. Hover an item to see the exact wording it came from.

About the website

Website quality (AI-assessed)
7/10 · Current news and pipeline updates; Contact and careers pages present
Footer copyright year
2021

Arthrosi Therapeutics is hiring

Open roles listed on their website as of Oct 14, 2026.

  • Sr. Clinical Accountant

Hiring in: Clinical

View careers page →

Recent changes

What changed on the Arthrosi Therapeutics website and Google listing, as detected by Coldlytics on each visit.

  1. Started advertising open roles

    Sr. Clinical Accountant

Coldlytics tracks changes like these across millions of businesses, so you can reach companies the moment they add a pixel, start hiring, or switch software.

Find companies by what just changed →

Biotech & Life Sciences Companies near CA

Browse all Biotech & Life Sciences companies in California →

Frequently Asked Questions about Arthrosi Therapeutics

Categories

Technologies Used

Key Decision Makers

Pamela Mundell Senior Clinical Trial Manager
LinkedIn
Wen Wei Senior Clinical Trial Manager
LinkedIn
Sarah de Guzman Senior Clinical Trial Manager
LinkedIn